Bio-Nutrion (CEO Kim Joo-young), which was selected in the health and well-being field of the National IT Industry Promotion Agency (NIPA)’s ‘2023 non-face-to-face leading service activation project in areas closely related to daily life’, provides ‘artificial intelligence-based customized nutrition and coaching (BIO-NUTRI). ) It is a company that helps ‘turn on’ the body’s metabolic switch to a healthy state. Currently, Bionutrion is growing into a company that produces digital treatment devices for the evaluation and management of non-alcoholic fatty liver disease. A demonstration project is being carried out with support from the National IT Industry Promotion Agency as a task to apply non-face-to-face customized nutritional prescriptions and digital coaching programs for the health management of patients with non-alcoholic fatty liver disease. In the future, our goal is to establish ourselves as a customized digital coach for all diseases that require weight control.
Non-alcoholic fatty liver disease rarely leads to cirrhosis and liver cancer, and the incidence of diabetes and cardiovascular disease is known to be 4 to 8 times higher. However, officials explain that there is still no cure and hospital-based systematic management is not working well. Accordingly, Bionutrion’s Dr. Coach has created an evidence-based weight loss program based on the results of a year of scientific research, consisting of an app and a dietary replacement.
Divided into an initial weight loss period and a lost weight maintenance period, we provide structured dietary therapy to ensure the effectiveness of medical treatment, and also provide cognitive behavioral therapy based on acceptance and commitment therapy and dialectical behavior therapy to help you improve your mind during the difficult journey of weight control. It helps us to hold on to the three again and move on. In addition, artificial intelligence-based dietary management and coaching programs will be combined to increase efficiency and scalability.
A Bionutrion official said, “Non-alcoholic fatty liver disease should be viewed as part of a systemic disease, not just a liver problem. It is difficult to control unless an integrated, systematic, and patient-centered treatment program is implemented. Recently released weight control drugs are recognized for their potential as a treatment for non-alcoholic fatty liver disease in terms of effectiveness, but the treatment does not end at once by suppressing just one of the various mechanisms that work in combination to worsen the disease. “He explained.
He continued, “Unless continuous management and mindset change are preceded, I believe that due to the characteristics of obesity, we must learn to manage it through disease control to maintain a safety line from yo-yo or recurrence. He emphasized, “The role of helping people control their lifestyle while simultaneously aiming at preventing and treating obesity is essential, and this is an area where Bionutrion would like to make a significant contribution.”
Through this demonstration project, we will be able to build trust by showing data in a strict scientific manner that Bionutrion’s program is showing meaningful results as a health management program for patients with steatohepatitis, and a health management program within the hospital. It is expected that it will serve as an important reference material when making a leap forward.
An official said, “The high-protein dietary substitute was originally sold as a protein health functional food, but due to the high cost, it was relaunched in the form of a weight control diet. “Dietary replacement products and apps are still in the verification business phase in terms of technological maturity, so they have not led to a rapid increase in sales, but we are gradually preparing to expand the hospital and seek to increase sales.”
Additionally, “Non-alcoholic fatty liver disease should be recognized as a disease that is close to a global pandemic. Therefore, Bionutrion wants to advance into the world and establish itself as a digital coaching program that can help with such control and management,” he said. “Until we obtain approval as a digital treatment device, we plan to expand our inroads into the non-insurance market through health checkup centers.” “After approval, we plan to make the app available for active prescriptions by gastroenterology departments at hospitals.”
Meanwhile, the National IT Industry Promotion Agency (NIPA, Director Heo Seong-wook) aims to promote the distribution of non-face-to-face services in areas closely related to people’s daily lives, such as business, daily consumption, education/evaluation, and well-being/health in the pandemic era. We are pursuing a ‘service revitalization project’. Starting in 2021, as the non-face-to-face digital economy accelerates across the economy and society in response to the great digital transformation in the post-corona era, this project will select and support key investment areas focusing on services that urgently require non-face-to-face transformation. Bionutrion has been selected in the health and wellness field.